BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Topics
» Ear, nose and throat, BioWorld Science
Ear, nose and throat, BioWorld Science
RSS
Auris Medical advances phase IIb trial of AM-111 for acute sensorineural hearing loss
Jan. 24, 2011
Neramexane mesilate is safe and well tolerated in subjects with tinnitus
Jan. 18, 2011
Auris Medical advances phase IIb trial of AM-111 in acute sensorineural hearing loss
Nov. 26, 2010
GenVec achieves milestone in collaboration with Novartis
Sep. 15, 2010
Otonomy closes Series B financing
Sep. 1, 2010
Topical nitroglycerin improves symptoms of chondrodermatitis nodularis helicis
Aug. 16, 2010
GenVec and Novartis expand collaboration on hearing loss and balance disorders
Aug. 9, 2010
Otonomy secures funds to advance OTO-104 and OTO-203
June 16, 2010
Otonomy receives FDA clearance for trial in Meniere's disease
Feb. 18, 2010
Previous
1
2
…
13
14
15
16
17
18
19
20
21
Next
RSS